WS Data Solutions
Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Buy
Debt to Equity Rating
Neutral
Price to Earnings Rating
Sell
Analyst Rating
Neutral
Simple Moving Average
Strong Sell
Exponential Moving Average
Strong Sell
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL)
Pharmaceutical Preparations
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.
1359 BROADWAY, SUITE 801
NEW YORK, NY
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
04/03/2020
Market Cap
227,545,600
Shares Outstanding
70,770,000
Weighted SO
70,765,771
Total Employees
N/A
Upcoming Earnings
08/14/2024
Beta
1.7060
Last Div
0.0000
Range
2.83-27.51
Chg
-0.0150
Avg Vol
1470477
Mkt Cap
227545600
Exch
NASDAQ
Country
US
Phone
212 433 3791
DCF Diff
3.4311
DCF
-0.2711
Div Yield
0.0000
P/S
5.3334
EV Multiple
-1.0361
P/FV
0.5942
Div Yield %
0.0000
P/E
-1.1679
PEG
0.1683
Payout
0.0000
Current Ratio
6.5917
Quick Ratio
6.5917
Cash Ratio
0.5544
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
5584.2814
CCC
-5584.2814
Gross Margin
0.9687
Op Margin
-5.1695
Pretax Margin
-4.5568
Net Margin
-4.5625
Eff Tax Rate
-0.0016
ROA
-0.3959
ROE
-0.4423
ROCE
-0.5190
NI/EBT
1.0012
EBT/EBIT
0.8815
EBIT/Rev
-5.1695
Debt Ratio
0.0895
D/E
0.1151
LT Debt/Cap
0.0975
Total Debt/Cap
0.1032
Int Coverage
-37.0615
CF/Debt
-3.7790
Equity Multi
1.2852
Rec Turnover
0.0000
Pay Turnover
0.0654
Inv Turnover
0.0000
FA Turnover
1.0993
Asset Turnover
0.0868
OCF/Share
-2.3420
FCF/Share
-2.3488
Cash/Share
6.0020
OCF/Sales
-3.8997
FCF/OCF
1.0029
CF Coverage
-3.7790
ST Coverage
-61.4164
CapEx Coverage
-343.0454
Div&CapEx Cov
-343.0454
P/BV
0.5942
P/B
0.5942
P/S
5.3334
P/E
-1.1679
P/FCF
-1.3637
P/OCF
-1.3663
P/CF
-1.3663
PEG
0.1683
P/S
5.3334
EV Multiple
-1.0361
P/FV
0.5942
DPS
0.0000